Juan Francisco Peña Cardelles, D.M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dental Implants | 7 | 2023 | 807 | 1.770 |
Why?
|
| Mouth Neoplasms | 4 | 2022 | 597 | 1.710 |
Why?
|
| Triclosan | 1 | 2022 | 58 | 0.790 |
Why?
|
| Stomatitis | 1 | 2021 | 271 | 0.620 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2021 | 640 | 0.570 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 2931 | 0.550 |
Why?
|
| Cannabis | 1 | 2022 | 446 | 0.530 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2021 | 4058 | 0.510 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2023 | 1003 | 0.480 |
Why?
|
| Hypersensitivity | 1 | 2022 | 1172 | 0.410 |
Why?
|
| Penicillins | 2 | 2022 | 406 | 0.300 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 2442 | 0.290 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 3781 | 0.260 |
Why?
|
| Hyperglycemia | 2 | 2023 | 1388 | 0.220 |
Why?
|
| Dental Implantation | 1 | 2022 | 48 | 0.200 |
Why?
|
| Povidone-Iodine | 1 | 2022 | 56 | 0.190 |
Why?
|
| Receptors, Mitogen | 1 | 2021 | 61 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 5 | 2023 | 7477 | 0.190 |
Why?
|
| Oral Surgical Procedures | 1 | 2023 | 172 | 0.180 |
Why?
|
| Tooth | 1 | 2022 | 210 | 0.180 |
Why?
|
| Computers | 1 | 2023 | 592 | 0.170 |
Why?
|
| Education, Dental | 1 | 2022 | 220 | 0.170 |
Why?
|
| Equipment Failure | 1 | 2022 | 585 | 0.160 |
Why?
|
| Biology | 1 | 2021 | 292 | 0.160 |
Why?
|
| Gingival Recession | 1 | 2022 | 210 | 0.160 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2023 | 459 | 0.160 |
Why?
|
| Alveolar Ridge Augmentation | 1 | 2021 | 209 | 0.150 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 594 | 0.150 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2023 | 1063 | 0.120 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 5889 | 0.110 |
Why?
|
| Bacteria | 1 | 2023 | 2216 | 0.100 |
Why?
|
| Prognosis | 2 | 2021 | 30010 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2023 | 4063 | 0.080 |
Why?
|
| Humans | 15 | 2023 | 768166 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3948 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2021 | 8741 | 0.070 |
Why?
|
| Dental Implantation, Endosseous | 2 | 2022 | 535 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2022 | 9384 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2021 | 4755 | 0.060 |
Why?
|
| Vestibuloplasty | 1 | 2022 | 3 | 0.050 |
Why?
|
| Hungary | 1 | 2022 | 82 | 0.050 |
Why?
|
| Oroantral Fistula | 1 | 2022 | 7 | 0.050 |
Why?
|
| Mouthwashes | 1 | 2022 | 57 | 0.050 |
Why?
|
| Dental Restoration Failure | 1 | 2022 | 156 | 0.050 |
Why?
|
| Dental Prosthesis Design | 1 | 2022 | 263 | 0.040 |
Why?
|
| Maxillary Sinus | 1 | 2022 | 175 | 0.040 |
Why?
|
| Dental Prosthesis, Implant-Supported | 1 | 2022 | 230 | 0.040 |
Why?
|
| Maxilla | 1 | 2022 | 488 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2022 | 1183 | 0.040 |
Why?
|
| Fibrin | 1 | 2022 | 514 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 12252 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2023 | 6430 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2022 | 2120 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 1238 | 0.030 |
Why?
|
| Viral Load | 1 | 2022 | 3396 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2021 | 1546 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2022 | 65371 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 10399 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 39348 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 54926 | 0.010 |
Why?
|
| Risk Factors | 1 | 2021 | 74944 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 81762 | 0.010 |
Why?
|
| Female | 1 | 2022 | 397192 | 0.000 |
Why?
|